San Francisco, CA, United States of America

James A Ernst

This inventor holds 16 USPTO granted patents and 6 published patent applications and 2 EPO patents, primarily in Bispecific Antibodies. Top assignees: Genentech, Inc., Adimab, LLC. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James A Ernst. Retrieved from https://idiyas.com/inventor/james-a-ernst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 68.8

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 126(Granted Patents)

Location History:

San Francisco, CA (US) (2010 - 2020)
South San Francisco, CA (US) (2018 - 2021)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2021

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-Transferrin Receptor

Anti-BACE1

Nucleic Acids

Beta-Klotho

Fibroblast Growth Factor

LRP6 Antibodies

Wnt Antagonists

Membrane-Spanning Proteins

Methods of Treatment

Antibody Production

Diagnosis and Treatment

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098129 - Anti-transferrin receptor antibodies and methods of use (2021-08-24),

2. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use (2021-05-18),

3. 10882921 - Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production (2021-01-05),

4. 10808036 - Anti-transferrin receptor antibodies and methods of use (2020-10-20),

5. 10508151 - Anti-transferrin receptor antibodies and methods of use (2019-12-17),

6. 10246518 - Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1 (2019-04-02),

7. 9884919 - Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 (2018-02-06),

8. 9873748 - Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 (2018-01-23),

9. 9708406 - Anti-transferrin receptor antibodies and methods of use (2017-07-18),

10. 9556267 - Anti-LRP6 antibodies (2017-01-31),

11. 8846041 - Anti-LRP6 antibodies (2014-09-30),

12. 8323902 - Methods for producing soluble membrane-spanning proteins (2012-12-04),

13. 7947277 - Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders (2011-05-24),

14. 7829684 - Methods for producing soluble membrane-spanning proteins (2010-11-09),

15. 7820806 - Methods for producing soluble membrane spanning proteins (2010-10-26),

Title: The Innovative Journey of James A. Ernst

Introduction: James A. Ernst is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries through his inventive spirit and dedication to technological advancement.

Latest Patents: James A. Ernst holds several patents in the fields of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, James A. Ernst has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, James A. Ernst has collaborated with top universities, innovative startups, and established corporations to bring his ideas to life, fostering a culture of creativity and collaboration in the innovation ecosystem.

Conclusion: James A. Ernst's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.